In the pharmaceutical space, Regeneron (NASDAQ:REGN), Onyx (NASDAQ:ONXX) and Celgene (NASDAQ:CELG) all had nice moves, and T3Live has listed them over the last few days.

FORBES: Google's Claws Toward $800, Apple Holds $430

Their returns this year range from the 57% of corporate information-data-services provider Teradata ( TDC), to 149% for drug designer and manufacturer Regeneron Pharmaceuticals ( REGN).

FORBES: 10 Companies That Prove Stock Picking Is Still Alive

Now comes a new glimmer of hope: a hunger-fighter called Axokine, from Regeneron Pharmaceuticals (nasdaq: REGN - news - people ) of Tarrytown, N.

FORBES: Hunger Pangs